Department of Ophthalmology (Guru Nanak Eye Centre), Maulana Azad Medical College, New Delhi, India ; and.
Department of Microbiology, Maulana Azad Medical College, New Delhi, India.
Cornea. 2021 Aug 1;40(8):1044-1047. doi: 10.1097/ICO.0000000000002742.
The purpose of this study was to report the analysis of reverse transcriptase polymerase chain reaction (RT-PCR) of nasopharyngeal (NP) samples of cornea donors dying because of causes unrelated to severe acute respiratory coronavirus (SARS-CoV-2).
A retrospective analysis of all cornea donors dying from causes other than SARS-CoV-2 between August 2020 and December 2020 was performed. Informed consent was obtained from the next of kin of the deceased for RT-PCR testing from NP swabs. Rapid antigen testing from all the deceased was performed before in situ cornea excision. In addition, NP samples in viral transport media for RT-PCR were also collected for SARS-CoV-2 analysis. Corneas were released from the eye bank only after a negative RT-PCR report.
One hundred eighteen corneas from 59 donors were obtained by the eye bank. Eleven donors (18.64%) were positive for SARS-CoV-2 on RT-PCR testing. Six of these 11 donors had a Ct value of E gene less than 25.
NP samples of cornea donors dying due to causes other than coronavirus disease-19 were positive for SARS-CoV-2 on RT-PCR. This implicates that donors could be having asymptomatic/undetected coronavirus disease infection. We recommend adding the routine testing of NP samples of all cornea donors in the eye banking protocol in this ongoing SARS-CoV-2 pandemic.
本研究旨在报告对因与严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)无关的原因而死亡的角膜供体的鼻咽(NP)样本进行逆转录聚合酶链反应(RT-PCR)分析。
对 2020 年 8 月至 2020 年 12 月期间因 SARS-CoV-2 以外的原因死亡的所有角膜供体进行了回顾性分析。获得死者家属的知情同意,对 NP 拭子进行 RT-PCR 检测。在原位角膜切除前,对所有死者进行了快速抗原检测。此外,还收集了用于 RT-PCR 的病毒运输介质中的 NP 样本以分析 SARS-CoV-2。只有在 RT-PCR 报告阴性后,眼库才会放行角膜。
眼库共获得 59 名供体的 118 个角膜。11 名供体(18.64%)的 RT-PCR 检测结果为 SARS-CoV-2 阳性。这 11 名供体中有 6 名 E 基因的 Ct 值小于 25。
因冠状病毒病-19 以外的原因死亡的角膜供体的 NP 样本经 RT-PCR 检测为 SARS-CoV-2 阳性。这表明供体可能存在无症状/未被发现的冠状病毒病感染。我们建议在当前的 SARS-CoV-2 大流行中,在眼库协议中增加对所有角膜供体 NP 样本的常规检测。